Gila Therapeutics

General Information
Company Name
Gila Therapeutics
Founded Year
2014
Location (Offices)
Boston, United States +1
Founders / Decision Makers
Number of Employees
5
Industries
Health Care
Funding Stage
Seed
Social Media

Gila Therapeutics - Company Profile

Gila Therapeutics is a Boston-based clinical stage biotech company founded in 2014 that is focused on addressing obesity, type 2 diabetes, and associated metabolic disorders. The company's innovative Topical Lingual Neural Signaling platform allows for the direct activation of specific brain regions responsible for metabolic regulation through the delivery of natural peptide hormones, aiming to minimize side effects. Gila Therapeutics boasts a distinguished scientific advisory team with expertise in endocrinology, neuroscience, and metabolic nephrology. The company recently secured a $355.52K Seed Round investment on 29 November 2022. With its pioneering approach and strong scientific backing, Gila Therapeutics presents an exciting opportunity in the health care industry.

Funding Rounds & Investors of Gila Therapeutics (5)

View All
Funding Stage Amount No. Investors Investors Date
Seed Round $355.52K - 29 Nov 2022
Debt Financing $401.93K - 16 Feb 2021
Venture Round $314.43K - 11 Mar 2019
Venture Round $760.16K - 18 Apr 2017
Series A $3.00M 4 28 Feb 2016

Latest News of Gila Therapeutics

View All

No recent news or press coverage available for Gila Therapeutics.

Similar Companies to Gila Therapeutics

View All
Teon Therapeutics Inc. - Similar company to Gila Therapeutics
Teon Therapeutics Inc. Teon is a clinical company targeting metabolic signaling pathways and pioneering the development of GPCR therapies
Complexa - Similar company to Gila Therapeutics
Complexa Advancing therapeutic innovation in human cell signaling for inflammation, fibrosis, and CNS disease treatment solutions.
Endogenex - Similar company to Gila Therapeutics
Endogenex Signaling a New Era in T2D Therapy
LiMM Therapeutics - Similar company to Gila Therapeutics
LiMM Therapeutics LiMM is the biopharmaceutical company harnessing the molecular cross-talk between neuronal and innate lymphoid cells.